SCHEMBL12187331

SCHEMBL12187331

CC(=N)C(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12176034 1.00
SCHEMBL11068641 0.75
SCHEMBL16945607 0.75
SCHEMBL24473931 0.74
SCHEMBL15937094 0.74
SCHEMBL20322830 0.74
SCHEMBL685471 0.73
SCHEMBL151855 0.73
Bromide SCHEMBL11092910 0.72
SCHEMBL8283923 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3293175-B1 METHODS FOR PURIFICATION OF SERINE PROTEASES ALEXION PHARMA INC (US) 2021-12-01 EP disclosed
EP-2569324-B1 AMINOGLYCOSIDE DERIVATIVES REMPEX PHARMACEUTICALS INC (US) 2017-12-06 EP disclosed
US-8906868-B2 Aminoglycoside derivatives REMPEX PHARMACEUTICALS, INC. (US) 2014-12-09 US disclosed
WO-2011143497-A1 AMINOGLYCOSIDE DERIVATIVES REMPEX PHARMACEUTICALS, INC. (US) 2011-11-17 WO disclosed
US-20090318437-A1 SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE MEDICINOVA, INC. 2009-12-24 US disclosed